The human mayor histocompatibility complex class I molecule HLA-A2 pre
ferentially binds peptides that contain Leu at P2 and Val or Leu at th
e C terminus. The other amino acids in the peptide also contribute to
binding positively or negatively. It is possible to estimate the bindi
ng stability of HLA-A2 complexes containing particular peptides by app
lying coefficients, deduced from a large amount of binding data, that
quantify the relative contribution of each amino acid at each position
. In this review, we describe the molecular basis for these coefficien
ts and demonstrate that estimates of binding stability based on the co
efficients are generally concordant with experimental measurements of
binding affinities. Peptides that contained cysteine were predicted le
ss well, possibly because of complications resulting from peptide dime
rization and oxidation. Apparently, peptide binding affinity is largel
y controlled by the rate of dissociation of the HLA/peptide/beta(2)-mi
croglobulin complex, whereas the rate of formation of the complex has
less impact on peptide affinity. Although peptides that bind tightly t
o HLA-A2, including many antigenic peptides bind much more weakly. The
refore, a full understanding of why certain peptides are immunodominan
t will require further research.